Your browser doesn't support javascript.
loading
Self-reported use of natural health products among rheumatology patients: A cross-sectional survey.
Hall, Jill J; Dissanayake, Tharindri D; Lau, Darren; Katz, Steven J.
Afiliación
  • Hall JJ; Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alta, Canada.
  • Dissanayake TD; Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alta, Canada.
  • Lau D; Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alta, Canada.
  • Katz SJ; Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alta, Canada.
Musculoskeletal Care ; 15(4): 345-349, 2017 12.
Article en En | MEDLINE | ID: mdl-28052563
ABSTRACT

OBJECTIVES:

To describe the self-reported use of natural health products (NHPs) and identify characteristics that predict selected NHP use in rheumatology patients.

METHODS:

We conducted a cross-sectional survey of consecutive rheumatology patients in two major clinics in Edmonton, Alberta. Survey items included demographic data, rheumatologic diagnoses, prescribed medications, NHPs, and information regarding patients' use of NHPs. Selected NHPs of interest - defined to include joint-specific products, oils with putative joint benefits, and other non-vitamin, non-mineral products - were classified by 2 reviewers. The characteristics of selected NHP users and non-users were compared using chi-squared and ANOVA tests, followed by multivariable-adjusted logistic regression.

RESULTS:

1063 patients completed the survey (response rate = 36%, mean age 53 [sd 15], 70% female). 36% of respondents reported using one or more of a wide range of selected NHPs (mean 1.8, range 1-9). The most common source of NHP recommendations for selected NHP users were physicians (42%). Significant predictors of selected NHP use were being female (aOR 1.41, 95%CI [1.05-1.90], p = 0.02), having a post-secondary degree (aOR 1.60 [1.15-2.22], p = 0.005), and the number of non-rheumatic medications (aOR 1.08 [ 1.00-1.15], p = 0.03) and NSAIDs (aOR 1.32 [1.06, 1.63], p = 0.01). Similar findings were observed among only inflammatory arthritis patients.

CONCLUSIONS:

Our study confirms the frequent use of selected NHPs, possibly to mitigate persistent symptoms of rheumatologic illness. Rheumatologists appear to be trusted sources of advice and recommendations on NHP use and should provide balanced counselling for their patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Suplementos Dietéticos Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Musculoskeletal Care Asunto de la revista: FISIOLOGIA / ORTOPEDIA Año: 2017 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Suplementos Dietéticos Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Musculoskeletal Care Asunto de la revista: FISIOLOGIA / ORTOPEDIA Año: 2017 Tipo del documento: Article País de afiliación: Canadá